ArticleOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery2025
Disclosure of Industry Relationships by Otolaryngologists.
Article in Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends in Industry-Sponsored Research Payments to Otolaryngologist Principal Investigators.The Laryngoscope · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to characterize how often otolaryngologists disclose relevant industry payments in publications and identify characteristics of these industry relationships. STUDY
designA cross-sectional database and bibliometric analysis.
settingOpen Payments Database and PubMed.
methodsPublications by the 10 highest-compensated otolaryngologists from each of 12 representative medical device and drug companies from 2018 to 2020 were assessed for disclosure of potential conflicts of interest in the years following payment through 2023.
resultsAfter excluding 52 physicians who did not publish in this period, 102 individuals received a combined $8,473,091.68, with an individual median of 15 payments (interquartile range [IQR] = 47) and median compensation of $18,522.77 (IQR = $53,965.52) from 1 or more of the 12 companies analyzed. The median number of publications per author was 10 (IQR = 25), and the median h-index of the authors was 16 (IQR = 28). Of the 1735 publications, 114 were classified as relevant, either because the study involved the evaluation of a device manufactured by one of the analyzed companies or because one of the companies funded the study. Of these, 23 (20.1%) were missing personal disclosure by the author. Of the physicians analyzed, the most represented subspecialty was rhinology (n = 47, 31%) followed by otology (n = 18, 11.8%).
conclusionAlthough most publications in the years following payments from device companies were not deemed to have potential conflicts of interest, a notable proportion of those with authors who received payments lacked relevant financial disclosure. As transparency of relevant industry relationships has received increased attention, appropriate disclosure is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.